resistant hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group: After the patient enters the study and opens the corresponding random envelope, he or she is placed in one of two intervention or control groups. In the interventio
placebo capsules are also prepared in the same place and with the same packaging so that there is no apparent difference between them.All patients are also urged to refrain from consuming cinnamon in
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 79 Years
Inclusion criteria
Inclusion criteria: Age between 40 and 79 years 10-year cardiovascular risk less than 10%
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in systolic and diastolic blood pressure. Timepoint: Measurements will be taken at baseline (time zero), two months, four months, and 6 months after the start of the study. Method of measurement: Patients' blood pressure will be measured manually in the clinic each time by one person (the attending physician).;Fasting blood sugar. Timepoint: Measurements will be taken at baseline (time zero), two months, four months, and 6 months after the start of the study. Method of measurement: By an accredited laboratory and as uniformly as possible for all patients.;Lipid profile. Timepoint: Measurements will be taken at baseline (time zero), two months, four months, and 6 months after the start of the study. Method of measurement: By an accredited laboratory and as uniformly as possible for all patients.;Body mass index. Timepoint: Measurements will be taken at baseline (time zero), two months, four months, and 6 months after the start of the study. Method of measurement: Using the formula and weighing the patient with a fixed scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Abdollahi Moghadam
Mashhad University of Medical Sciences
Outcome results
None listed